75000 - Document - Cover
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Condensed Consolidated Statement of Operations and Comprehensive Loss (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75070 - Statement - Condensed Consolidated Statements Of Cash Flows (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75080 - Statement - Condensed Consolidated Statements Of Cash Flows (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Nature of the Business and Basis of Presentation
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Reverse Recapitalization and Pre-Closing Financing
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Investments
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Accrued Expenses and Other Current Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Convertible Notes Payable
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Convertible Preferred Stock and Stockholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Stock-Based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Significant Agreements
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Leases
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Net Loss per Share
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Segment Reporting
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Reverse Recapitalization and Pre-Closing Financing (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Investments (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Fair Value Measurements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Stock-Based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Leases (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Net Loss per Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Related Party Transactions (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Segment Reporting (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Nature of the Business and Basis of Presentation - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Life of Property and Equipment (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Reverse Recapitalization and Pre-Closing Financing - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Reverse Recapitalization and Pre-Closing Financing - Schedule of Recapitalization, Asset Acquired and Liability Assumed (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Investments - Summary of Investment Portfolio (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Investments - Schedule of Fair Value of Company's Investments, by Contractual Maturity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Fair Value Measurements - Schedule of Fair Value Instruments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Fair Value Measurements - Schedule of Assumptions Related to The Change in Fair Value (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Convertible Notes Payable - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Schedule of Series A Non-Voting Preferred Stock (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Summary of Shares Available for Issuance (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Stock-Based Compensation - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Stock-Based Compensation - Schedule of Assumptions used in Calculating the Fair Value (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Units and Restricted Stock Awards Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) [Default]
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Stock-Based Compensation - Schedule of Award Types of Stock-Based Compensation Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Income Taxes - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Significant Agreements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Significant Agreements - Additional Information (Details) [Default]
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Leases - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Leases - Schedule of Total Remaining Operating Lease Payments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - Leases - Schedule of Total Remaining Operating Lease Payments (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Commitments and Contingencies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Net Loss per Share - Schedule of Basic and Diluted Net Loss Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996015 - Disclosure - Net Loss per Share - Schedule of Basic and Diluted Net Loss Per Share (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996025 - Disclosure - Net Loss per Share - Schedule of Potential Shares of Common Stock Excluded from Computation of Diluted Net Loss Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996035 - Disclosure - Related Party Transactions - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996045 - Disclosure - Related Party Transactions - Schedule of Related Party Accounts Payable and Other Current Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996055 - Disclosure - Segment Reporting - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996065 - Disclosure - Segment Reporting - Summary Of Significant Expense Categories For The Segment (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996075 - Disclosure - Subsequent Events - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Related Party Transaction [Table]
Shares Outstanding Percentage
Shares outstanding percentage.
Share outstanding percentage
Basis of Presentation and Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Scenario [Axis]
Convertible Preferred Stock, Shares Issued upon Conversion
Convertible shares
Common Stock, Capital Shares Reserved for Future Issuance
Common stock reserved for future issuance
Shares reserved for issuance
SCHEDULE OF ACCRUED AND OTHER CURRENT LIABILITIES
Schedule of Accrued Expenses and Other Current Liabilities
Preferred stock, shares issued
Preferred stock, shares issued
Preferred Stock Issued
Debt Disclosure [Text Block]
Convertible Notes Payable
Operating Lease, Liability
Present value of net minimum lease payments
Total present value of operating lease liability
Lease liability
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total
Unrecognized stock based compensation cost
Warrant Liability, Related Party
Warrant liability, related party.
Warrant liability, related party
Commitments and Contingencies
Commitments and contingencies (Note 12)
Weighted Average Number of Shares Outstanding, Diluted, Total
Weighted Average Shares Outstanding, Diluted
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted
Stock based compensation
Stock-based compensation
Operating lease term
Operating lease term
Minimum
Minimum
Preferred stock, shares outstanding
Preferred stock, shares outstanding
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred Stock Outstanding
2026 Employment Inducement Stock Incentive Plan
Two Thousand Twenty Six Employment Inducement Stock Incentive Plan [Member]
Two Thousand Twenty Six Employment Inducement Stock Incentive Plan.
Fair Value, Recurring [Member]
Fair Value, Recurring
Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block]
Schedule of Recapitalization, Asset Acquired and Liability Assumed
Consolidated Entities [Domain]
Common stock, shares issued
Common stock, shares issued
Segment Reporting [Line Items]
Segment Reporting
Debt Instrument, Face Amount
Aggregate principal amount
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Number of options, vested and exercisable
Income Tax Expense (Benefit)
Income Tax Expense (Benefit), Total
Income tax expense
Income tax expense
At The Market Offering [Member]
At The Market Offering [Member]
ATM
Long Term Investments [Member]
Long term investments.
Non-current Investments
Related Party Transaction [Line Items]
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
Due after one year through five years
Restricted Stock Units (RSUs) [Member]
Restricted Stock Units
Outstanding and Issued Restricted Stock Units
Percentage of Gross Proceeds from Sold Shares
Percentage of gross proceeds from sold shares
Precentage of gross proceeds from shares sold
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Common stock warrants exercisable
Common stock warrant issued
Operating Segments [Member]
Operating Segments
Stock Issued During Period, Value, Conversion of Convertible Securities
Exchange of Series Seed convertible preferred stock for Series A non-voting convertible preferred stock upon the closing of the reverse recapitalization
Debt Securities, Available-for-Sale, Amortized Cost
Amortized Cost
Subsequent Event Type [Domain]
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Less: Imputed interest
Interest payments over the initial lease term
Nonoperating Income (Expense)
Total other income (expense), net
Schedule of Long-Term Debt Instruments [Table]
Percentage on total number of shares outstanding
General and administrative
General and administrative
General and Administrative Expense, Total
General and administrative expense
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
Share Repurchase Program, Remaining Authorized, Number of Shares
Number of remaining shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Number of RSUs and RSAs, Forfeited
Number of RSUs and RSAs, Forfeited
Fairmount Funds Management LLC [Member]
Fairmount funds management LLC.
Fairmount
Related and Nonrelated Parties [Domain]
Net loss per share attributable to common stockholders, basic
Loss Per Share - Basic
Earnings Per Share, Basic, Total
Loss Per Share - Basic
Measurement Input, Term
Long-Term Debt, Term
Document Period End Date
Two Thousand Twenty Five Equity Incentive Plan [Member]
Two thousand twenty five equity incentive plan.
2025 Equity Incentive Plan
Fee for nomination of a development candidate
Fee for Nomination of a Development Candidate
Fee for nomination of a development candidate.
Accrued Research And Development Contract Costs
Accrued research and development contract costs.
Accrued research and development contract costs
Expiration period
Expiration period
Purchases of property and equipment
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment, Total
Purchases of property and equipment
Debt Instrument [Line Items]
Weighted-average exercise price, granted
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Additional Development Costs Incurred
Additional development costs incurred.
Additional development costs incurred
Percentage of Outstanding Capital Stock to Grant Warrants
Percentage of outstanding capital stock to grant warrants.
Percentage of outstanding capital stock to grant warrants
Common stock, shares authorized
Common stock, shares authorized
Statement of Stockholders' Equity [Abstract]
Expected to issue on December 31, 2026
December 31, 2026 [Member]
December 31, 2026.
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
Prepaid expenses and other current assets
Total prepaid expenses and other current assets
Prepaid expenses and other current assets
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Foreign Currency and Currency Translation
Cash Acquired In Connection With The Reverse Recapitalization
Cash acquired in connection with the reverse recapitalization.
Cash acquired in connection with the reverse recapitalization
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value
Fair value of restricted stock awards vested
Investments [Domain]
Debt Instrument, Interest Rate, Stated Percentage
Interest rate
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Aggregate intrinsic value outstanding, beginning balance
Aggregate intrinsic value
Aggregate intrinsic value outstanding, ending balance
Nonmonetary Transaction Type [Axis]
Assets [Default Label]
Total assets
Title of 12(b) Security
Loss Contingency, Nature [Domain]
Preferred Stock, Value, Issued
Carrying Value
Series A non-voting convertible preferred stock, $0.0001 par value; 12,622 shares authorized as of both June 30, 2026 and December 31, 2025, 12,622 shares issued and outstanding as of both June 30, 2026 and December 31, 2025
Related Party Transaction [Axis]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Number of RSUs and RSAs, beginning
Number of RSUs and RSAs, ending balance
Restricted stock awards, outstanding
Stock Issued During Period, Value, Stock Options Exercised
Exercise of stock options
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE
Schedule of Stock-Based Compensation Expense
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Number of options, granted
Non-qualified stock options granted to purchase common stock
Title and Position [Domain]
Restricted stock awards.
RSAs
Restricted stock awards
Outstanding and unvested RSAs
Antidilutive Securities, Name [Domain]
Liabilities, Fair Value Disclosure [Abstract]
Liabilities
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized
Number of additional shares authorized
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
remaining 6 months in 2026
Convertible Note Principal And Non Cash Accrued Interest Converted To Common Stock And Pre Funded Warrants
Convertible note principal and non-cash accrued interest converted to common stock and pre-funded warrants.
Convertible note principal and non-cash accrued interest converted to common stock and pre-funded warrants
Accrued interest
Interest Paid, Excluding Capitalized Interest, Operating Activity
Temporary Equity, Value, Conversion of Convertible Securities
Temporary equity, value, conversion of convertible securities.
Temporary equity, exchange of series seed convertible preferred stock for series a non-voting convertible preferred stock upon the closing of the reverse recapitalization
Number of votes per each employee
Number of Votes Per Each Employee
Number of votes per each employee.
Weighted Average Number Of Shares, Shares Converted
Weighted average number of shares, shares converted
Weighted average number of shares, shares converted.
Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]
Lessee, Operating Lease, Liability, to be Paid, Year One
2027
Two Thousand Twenty Four Equity Incentive Plan [Member]
Two thousand twenty four equity incentive plan.
2024 Equity Incentive Plan
Noncash or Part Noncash Acquisition, Other Assets Acquired
Prepaids and other current assets acquired in connection with the reverse recapitalization
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term
Weighted-average remaining contractual term (in years)
Segment Reporting [Table Text Block]
Summary Of Significant Expense Categories For The Segment
Paragon Option Agreement
Paragon Option Agreement [Member]
Paragon option agreement.
Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross
Development costs incurred
Operating lease liabilities
Increase (Decrease) in Operating Lease Liability
Lessee, Operating Leases [Text Block]
Leases
Received from related party amount
Proceeds from Related Party Debt
Nonrefundable Sublicensee Fee
Nonrefundable sublicensee fee.
Nonrefundable sublicensee fee
October PIPE Financing [Member]
October PIPE financing.
Stockholders' Equity Attributable to Parent
Beginning balance
Ending balance
Total stockholders' equity
Entity Address, Address Line Two
Purchase Agreement [Member]
Purchase agreement.
Purchase Agreement
Other Assets, Noncurrent
Other assets
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Income Taxes
Income Tax Disclosure [Text Block]
Borrowings rate of return
Borrowings Rate of Return
Borrowings rate of return
Earnings Per Share [Text Block]
Net Loss per Share
Cash, Cash Equivalents and Investments
Cash, cash equivalents and investments.
Cash and cash equivalents, and investments
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
Due within one year
October 2025 Private Placement
October 2025 Private Placement[Member]
October 2025 Private Placement.
Losses incurred to date
Loss Contingency, Losses Incurred To Date
Loss contingency, losses incurred to date.
Number of Reportable Segments
Number of reportable segments
Stock, Class of Stock [Table]
Temporary Equity, Par or Stated Value Per Share
Temporary equity, par value
Purchase price per share
Interest income
Interest income
Interest income
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax
Unrealized gains
Restricted Stock Awards
RSAs
Outstanding and unvested Restricted stock units
Weighted Average Grant date fair value, Vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Proceeds from stock option exercises
Proceeds from Stock Options Exercised
Loss Contingency Nature [Axis]
Stock Issued During Period, Shares, Conversion of Convertible Debt
Stock issued during period, shares, conversion of convertible debt.
Conversion of convertible notes (including accrued interest and discount) into pre-funded warrants upon the closing of the reverse recapitalization (in shares)
Warrants Converted, Reverse Recapitalization
Warrants converted, reverse recapitalization.
Warrants converted (in shares)
Schedule Of Award Types Of Company'S Stock Based Compensation Expense [Abstract]
Schedule of award types of company's stock based compensation expense.
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]
Property and equipment, estimated useful life
Statistical Measurement [Axis]
Milestone payments
Payment for Milestone
Payment for milestone.
Money Market Funds [Member]
Money Market Funds
Entity Interactive Data Current
Cell Line License Agreement [Member]
Cell Line License Agreement.
Cell Line License Agreement
Lessee, Operating Lease, Liability, to be Paid, Year Three
2029
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common Stock, Value, Issued
Common stock, value
Common stock, $0.0001 par value; 300,000,000 shares authorized as of June 30, 2026 and December 31, 2025, respectively; 63,556,065 and 49,316,287 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of Basic and Diluted Net Loss Per Share
US Government Agencies Debt Securities [Member]
U.S. Government-sponsored Agency Securities
Other liabilities assumed in connection with the reverse recapitalization
Noncash or Part Noncash Acquisition, Other Liabilities Assumed
Other liabilities assumed in connection with the reverse recapitalization
Property, Plant, and Equipment [Policy Text Block]
Property and Equipment
Liabilities
Total liabilities
Ownership [Domain]
SCHEDULE OF FAIR VALUE INSTRUMENTS
Schedule of Fair Value Instruments
Short-Term Investments [Member]
Short-Term Investments
Current Investments
Accumulated deficit
Accumulated deficit
Fair Value, Inputs, Level 3 [Member]
Fair Value, Inputs, Level 3
Pre Funded Warrants [Member]
Pre Funded Warrants
Pre-Funded Warrants
Increase (Decrease) in Accounts Payable
Accounts payable
Operating Expenses
Total operating expenses
Preferred Stock, Convertible, Shares Issuable
Common Stock Issuable Upon Conversion
Potential Milestone Payments Required to be Paid
Potential milestone payments required to be paid.
Potential milestone payments required to be paid
Percentage of royalty reduction
Percentage of Royalty Reduction
Percentage of royalty reduction.
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Nature of the Business and Basis of Presentation
Fair Value Measurement Inputs and Valuation Techniques [Table]
Changes in operating assets and liabilities:
Changes in operating assets and liabilities:
Vested term
Stock Issued During Period, Shares, New Issues
Issuance of common stock, (in shares)
Fairmount Healthcare Fund [Member]
Fairmount Healthcare Fund.
Fairmount
Warrants outstanding
Class of Warrant or Right, Outstanding
Temporary Equity, Carrying Amount, Attributable to Parent
Temporary equity, ending balance
Temporary equity, beginning balance
Carrying Value
Series Seed convertible preferred stock, $0.0001 par value; no shares and 20,000,000 shares authorized as of September30, 2025 and December 31, 2024, respectively; no shares and 20,000,000 issued and outstanding as of September 30, 2025 and December 31,2024, respectively; liquidation preference of $2 as of December 31, 2024 and none as of September 30, 2025, respectively.
Related Party Transactions [Abstract]
2021 Plan and 2018 Plan [Member]
2021 Plan and 2018 Plan
Long-Lived Asset, Class [Axis]
Subsequent Events [Text Block]
Subsequent Events
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation, Total
Effect of exchange rates on cash and cash equivalents
Fair Value Hierarchy and NAV [Axis]
Expected volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Assets, Fair Value Disclosure [Abstract]
Assets:
Property, Plant, and Equipment [Line Items]
Corporate Debt Securities [Member]
Corporate Debt Securities
Probability of Next Equity Financing / prior to trade sale
Measurement Input Probability of Next Equity Financing and Prior to Trade Sale [Member]
Measurement input probability of next equity financing and prior to trade sale.
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Risk-free interest rate
Labor and Related Expense
Employee costs
General and administrative personnel-related costs (including stock-based compensation)
Equity Ownership, Excluding Consolidated Entity and Equity Method Investee, Percentage
Ownership percentage
Debt Securities, Available-for-Sale
Fair value
Total
Payments of Stock Issuance Costs
Issuance of common stock
Parade Warrant Obligation [Member]
Parade Warrant Obligation.
Parade Warrant Obligation
Weighted Average Grant date fair value, beginning
Weighted Average Grant date fair value, Ending
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Estimated Fair Value Of Warrants To Be Granted
Estimated fair value of warrants to be granted.
Fair value of warrants
Business Combination, Recognized Liability Assumed, Liability
Net liabilities assumed
Net liabilities assumed
Liabilities and Equity
Total liabilities and stockholders' equity
Expected dividend yield
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Merger Agreement, Shares To Be Issued, Denominator For Calculation
Refers shares to be issued in denominator for calculation under merger agreement.
Shares to be issued in denominator for calculation
Lessee, Operating Lease, Liability, to be Paid, Year Two
2028
Research and development
Research and Development Expense, Total
Research and development
External research and development costs
Proceeds from Issuance of Common Stock And Pre Funded Warrants
Proceeds from issuance of common stock and pre funded warrants
Aggregate amount of pre funded warrant
Lessee, Lease, Description [Table]
Document Fiscal Period Focus
Maximum sublicensing fees
Maximum sublicensing fees.
Maximum Sublicensing Fees
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of Assumptions Used in Calculating the Fair Value
June Financing [Member]
June financing.
Title and Position [Axis]
Property, Plant, and Equipment [Table]
Sale of Stock [Axis]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Weighted-average exercise price, vested and exercisable
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Net increase in cash and cash equivalents
Entity Current Reporting Status
Chief Medical Officer [Member]
Chief medical officer.
Chief Medical Officer
Convertible Notes Payable [Member]
Convertible Notes Payable
Convertible Notes
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 1
Class of Stock [Domain]
Research and development personnel-related costs
Research and development personnel-related costs (including stock-based compensation)
Research and development personnel-related costs (including stock-based compensation)
JADE201 [Member]
JADE201.
JADE201
Accounts payable
Accounts payable
Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Diluted Stock
Share based compensation arrangement by share based payment award percentage of diluted stock.
Percentage of diluted stock
Investment Type [Axis]
Project [Domain]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Potential Shares of Common Stock Excluded from Computation of Diluted Net Loss Per Share
Financial Instrument [Axis]
Assets, Fair Value Disclosure
Total assets
Increase (Decrease) in Other Noncurrent Assets
Other assets
Document Transition Report
Commitments and Contingencies Disclosure [Abstract]
Subsequent Event [Line Items]
Class of Warrant or Right [Axis]
JADE Three Zero One [Member]
JADE Three Zero One.
JADE -301
Current liabilities:
Current liabilities:
Stock-Based Compensation
Common Stock [Member]
Common Stock
Statistical Measurement [Domain]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
June 2026 Financing [Member]
June 2026 financing.
June 2026 Financing
Other income (expense):
Other income (expense):
Non refundable reservation fee
Non Refundable Reservation Fee
Non refundable reservation fee.
Debt Securities, Available-for-Sale [Line Items]
Unrealized loss on investments
Debt Securities, Trading, Unrealized Gain (Loss)
Debt Securities, Trading, Unrealized Gain (Loss), Total
Stockholders' equity:
Stockholders' equity
Weighted-average common stock outstanding, basic
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted Average Shares Outstanding, Basic
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic
Assets
Assets
Operating Lease, Expense
Non-cash lease expense
Operating lease expense
Entity Central Index Key
Lessee, Operating Lease, Remaining Lease Term
Remaining lease term
Antidilutive Securities [Axis]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Acquisitions
Issuance of common stock to former stockholders of Aerovate in connection with the closing of the reverse recapitalization (in shares)
Issuance of common stock to former stockholders of Aerovate in connection with the closing of the reverse recapitalization (in shares)
Consolidation Items [Axis]
Current Fiscal Year End Date
Class of Warrant or Right [Domain]
Document Quarterly Report
Entity Address, Address Line Three
Net Income (Loss) Available to Common Stockholders, Diluted
Net Income (Loss) Available to Common Stockholders, Diluted, Total
Loss Allocation, Diluted
Reimbursable Legal Fees [Member]
Reimbursable legal fees.
Reimbursable Legal Fees
Debt Securities, Available-for-Sale [Table]
Number of Employees in Joint Development Committee
Number of employees in joint development committee.
Number of employees in joint development committee
Award Date [Domain]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 2
Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent
Cash and cash equivalents
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Weighted-average exercise price outstanding, ending balance
Weighted-average exercise price outstanding, beginning balance
Unrealized Gain (Loss) on Investments
Unrealized loss on investments
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Net cash used in operating activities
Net cash used in operating activities
Entity Incorporation, State or Country Code
Net loss per share attributable to common stockholders, diluted
Earnings Per Share, Diluted, Total
Loss Per Share - Diluted
Loss Per Share - Diluted
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
Common stock available for issuance, awards granted
Sale of Stock, Number of Shares Issued in Transaction
Common stock issued and sold
Preferred stock, par value
Preferred stock, par value
Net loss, Basic
Net loss
Net loss
Net loss
Net loss
Ownership [Axis]
Proceeds from sales/maturities of investments
Proceeds from Sale, Maturity and Collection of Investments
Proceeds from Sale, Maturity and Collection of Investments, Total
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies
Long-Lived Asset, Class [Domain]
Number of Pre-funded Warrants Exercised for Common Stock
Number of pre-funded warrants exercised for common stock.
Number of pre-funded warrants exercised for common stock
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive loss
Nonmonetary Transaction Type [Domain]
Measurement Input Probability of Next Equity Financing [Member]
Measurement input probability of next equity financing.
Probability of Next Equity Financing
Measurement Frequency [Domain]
Scenario [Domain]
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total
Currency translation adjustment
Debt Instrument, Fair Value Disclosure, Total
Debt Instrument, Fair Value Disclosure
Debt fair value
Equity Components [Axis]
Cash flow from investing activities:
Cash flows from investing activities:
Collaborative Arrangement Disclosure [Text Block]
Significant Agreements
Condensed Consolidated Statements of Cash Flows (Unaudited)
JADE-001
JADE Zero Zero One [Member]
JADE zero zero one.
Fair Value Hierarchy and NAV [Domain]
Income Tax Disclosure [Abstract]
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
Schedule of Related Party Accounts Payable and Other Current Liabilities
Reverse stock split
Stockholders' Equity, Reverse Stock Split
Further Milestone Payment
Further milestone payment
Further milestone payment.
Weighted-average exercise price, exercised
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted average grant date fair value
Deferred Offering Costs
Offering costs
Increase (Decrease) in Prepaid Expense and Other Assets
Prepaid expenses and other current assets
Fair Value Disclosures [Text Block]
Fair Value Measurements
Special development and regulatory milestones payment
Specific Development and Regulatory Milestones Payment
Specific development and regulatory milestones payment.
Preferred stock, shares authorized
Preferred stock, shares authorized
Preferred Stock Authorized
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax
Unrealized loss on investments
Class of Stock [Axis]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Total anti-dilutive shares
Tabular disclosure of common stock shares reserved on and as converted basis for future issuance.
SCHEDULE OF COMMON STOCK SHARES RESERVED FOR FUTURE ISSUANCE
Summary of Shares Available for Issuance
Project [Axis]
Prior Written Notice Period to Terminate
Prior written notice period to terminate.
Prior written notice period to terminate
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive (Loss) Income
Available for future grant
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Temporary Equity, Shares Outstanding
Temporary equity, shares outstanding
Temporary equity, beginning balance (in shares)
Temporary equity, ending balance (in shares)
Preferred Stock Outstanding
Accrued interest
Interest Receivable
Accrued and other liabilities
Accrued expenses and other current liabilities
Weighted-average exercise price, forfeited
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Other research and development costs
Other Research and Development Expense
Total accrued expenses and other current liabilities
Accrued Liabilities, Current
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Common stock options granted and outstanding
Number of options outstanding, beginning balance
Number of options outstanding, ending balance
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]
Award Date [Axis]
Discount rate
Measurement Input, Discount Rate [Member]
Unrealized losses
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Document Type
Cash and Cash Equivalents
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash flow from operating activities:
Cash flows from operating activities:
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Liabilities and Stockholders' Equity
Liabilities and Stockholders' Equity
Lessee, Lease, Description [Line Items]
Stock Option Valuation
Subsequent Event
Subsequent Event [Member]
Operating Income (Loss)
Total operating expenses
Total operating expenses
Loss from operations
Measurement Input, Risk Free Interest Rate [Member]
Interest rate
Intangible Assets
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total
Segment Reporting [Table]
Asset Class [Domain]
Entity File Number
Schedule of Stock by Class [Table Text Block]
Schedule of Series A Non-Voting Preferred Stock
Accrued Liabilities and Other Liabilities
Accrued expenses and other current liabilities balance
Lessee, Operating Lease, Liability, Maturity [Table Text Block]
Schedule of Total Remaining Operating Lease Payments
Location, Statement of Income, Balance [Axis]
Retained Earnings [Member]
Accumulated Deficit
Proceeds from (Payment for) Other Financing Activity
Proceeds from the Pre-Closing Financing, net of 14,548 of offering costs
Investment in Debt and Equity Securities and Other Trading Assets [Text Block]
investments
December PIPE Financing [Member]
December PIPE financing.
Entity Registrant Name
Accounting Policies [Abstract]
Depreciation and amortization expense
Depreciation, Total
Depreciation expense
Net loss
Net loss
Loss Allocation
Net loss
Proceeds from Issuance of Debt
Proceeds from financing
Gross proceeds from issuance of additional debt
Stock issued during period, value, conversion of convertible debt.
Conversion of convertible notes (including accrued interest and discount) into pre-funded warrants upon the closing of the reverse recapitalization
Stock Issued During Period, Value, Conversion of Convertible Debt
Entity Address, Address Line One
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]
Accrued Expenses and Other Current Liabilities
Nonrefundable License Fee
Non-refundable license fee
Nonrefundable license fee.
Subsidiary, Sale of Stock [Line Items]
Sale of Stock
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Options Exercised
Number of options, exercised
Exercise of stock options (in shares)
Assets, Current
Total current assets
Fair Value, Recurring and Nonrecurring [Table]
Issuance costs of financing
Issuance Costs Of Financing.
Issuance costs of financing.
Net Loss Per Share
Net Loss per Share Attributable to Common Stockholders
Segments [Axis]
Loss Contingencies [Line Items]
Related Party Transactions Disclosure [Text Block]
Related Party Transactions
Measurement Input
Long-Term Debt, Measurement Input
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. [Member]
Aerovate Therapeutics, Inc.
Aerovate
Entity Small Business
Adjustments to Additional Paid in Capital, Shares, Issuance of Common Stock to Former Stockholders Upon Closing of Reverse Recapitalization
Adjustments to additional paid in capital, shares, issuance of common stock to former stockholders upon closing of reverse recapitalization.
Issuance of common stock to former stockholders of Aerovate in connection with the closing of the reverse recapitalization (in shares)
JADE101 [Member]
JADE101.
JADE101
Granted on December 31, 2025
December 31, 2025 [Member]
December 31, 2025.
Paragon
Paragon [Member]
Paragon.
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Weighted Average Grant date fair value, Forfeited
Long-Term Debt, Type [Axis]
JADE Zero Zero Three [Member]
Jade zero zero three.
JADE-003
Stock Issued During Period, Values, Exercise of Pre Funded Warrants
Stock Issued During Period, Values, Exercise of Pre Funded Warrants
Issuance of common stock in connection with exercise of pre-funded warrants
Consolidation Items [Domain]
Reverse Recapitalization and Pre-Closing Financing
Reverse Recapitalization and Pre Closing Financing [Text Block]
Reverse recapitalization and pre-closing financing.
Employee-related Liabilities, Current
Accrued payroll and other employee benefits
Employee-related Liabilities, Current, Total
Accrued employee compensation and benefits
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Earnings Per Share [Abstract]
Indemnification Agreement
Indemnification Agreement [Member]
Investments
Investment, Policy [Policy Text Block]
SCHEDULE OF OPTION ACTIVITY UNDER 2021 PLAN AND 2018 PLAN
Schedule of Stock Option Activity
2021 Stock Option and Incentive Plan [Member]
2021 Stock Option and Incentive Plan
Convertible Common Stock [Member]
Convertible Common Stock
Lessee, Operating Lease, Liability, to be Paid, Year Four
2030
Achievement of Certain Clinical Development Milestones [Member]
Achievement of certain clinical development milestones.
Achievement of Certain Clinical Development Milestones
Series A Convertible Preferred Stock
Series A Convertible Preferred Stock [Member]
Series A Convertible Preferred Stock.
Plan Name [Axis]
Loss contingency liability
Loss Contingency Accrual
Loss Contingency Accrual, Ending Balance
Loss Contingency Accrual, Beginning Balance
Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted, Total
Loss Allocation, Diluted
Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted
Subsequent Event Type [Axis]
Equity [Abstract]
Achievement of Certain Regulatory Milestones [Member]
Achievement of certain regulatory milestones.
Achievement of Certain Regulatory Milestones
Proceeds from Convertible Debt
Proceeds from issuance of convertible notes
Proceeds from issuance of Convertible Notes payable
Stockholders' Equity Note Disclosure [Text Block]
Convertible Preferred Stock and Stockholders' Equity
Measurement Frequency [Axis]
Cash flow from financing activities:
Cash flows from financing activities:
Pre-Merger Pre-Funded Warrants [Member]
Pre-Merger pre-funded warrants.
Pre-Merger Pre-Funded Warrants
Consolidated Entities [Axis]
Sale Agreement [Member]
Sale Agreement
Sale Agreement
Marketable Securities, Noncurrent
Non-current marketable securities
Issuance costs of Pre-Closing Financing and reverse recapitalization
Adjustments to Additional Paid in Capital, Issuance Costs Of Financing And Reverse Recapitalization
Adjustments to additional paid in capital, issuance costs of financing and reverse recapitalization.
Entity Tax Identification Number
Stock Issued During Period, Shares, Conversion of Convertible Securities
Exchange of Series Seed convertible preferred stock for Series A non-voting convertible preferred stock upon the closing of the reverse recapitalization (in shares)
Milestone payment and recorded the payment as research and development
Milestone Payment and Recorded the Payment as Research and Development
Milestone payment and recorded the payment as research and development.
Reimbursable Fees [Member]
Reimbursable fees.
Reimbursable Fees
Schedule of Estimated Useful Life of Property and Equipment
Schedule Of Property And Equipment Estimated Useful Life [Table Text Block]
Schedule of property and equipment estimated useful life.
Paragon Therapeutics
Paragon Therapeutics.
Paragon Therapeutics
Equity Component [Domain]
Increase (Decrease) in Accrued Expenses and Other Current Liabilities, Related Parties
Increase (decrease) in accrued expenses and other current liabilities, related parties.
Related party accrued expenses and other current liabilities
Entity Address, City or Town
Year-to-date tax liability related to the Jade Biosciences Canada ULC foreign subsidiary.
Foreign Income Tax Expense (Benefit), Continuing Operations
Foreign Income Tax Expense (Benefit), Continuing Operations, Total
Measurement Input Type [Domain]
Purchases of property and equipment in accounts payable
Capital Expenditures Incurred but Not yet Paid
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic, Total
Loss Allocation, Basic
Issuance of common stock
Stock Issued During Period, Value, New Issues
Segments [Domain]
Change in fair value of Convertible Notes payable
Change In Fair Value Of Convertible Notes Payable
Change in fair value of convertible notes payable.
Change in fair value of Convertible Notes payable
Entity Common Stock, Shares Outstanding
Investments Classified by Contractual Maturity Date [Table Text Block]
Schedule of Fair Value of Company's Investments, by Contractual Maturity
Commercial Paper [Member]
Commercial Paper
Entity [Domain]
Jade Biosciences Inc [Member]
Jade Biosciences Inc.
Jade Biosciences Inc
Number of finance lease
Number of Finance Lease
Number of finance lease.
Antidilutive Security, Excluded EPS Calculation [Table]
Time from Convertible Notes issuance to Next Equity Financing / prior to trade sale (in years)
Measurement Input Time from Convertible Notes Issuance to Next Equity Financing and Prior to Trade Sale [Member]
Measurement input time from convertible notes issuance to next equity financing and prior to trade sale.
Statement [Table]
Share-Based Payment Arrangement, Expense
Stock-based compensation
Stock-based compensation expense
Stock-based compensation expense
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Net loss before income tax expense
Net loss before income tax expense
Entity Shell Company
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Expected term (in years)
Accounts Payable and Other Accrued Liabilities, Current
Related party accounts payable and other current liabilities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net cash used in investing activities
Statement [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Number of RSUs and RSAs, Vested
Maximum [Member]
Maximum
Proceeds from ESPP issuances
Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised
Business Combination, Recognized Asset Acquired, Prepaid Expense and Other Asset, Current
Prepaids and other current assets
Debt Disclosure [Abstract]
Sale of Stock [Domain]
Temporary Equity, Shares Issued
Shares issued to related party
Preferred Stock Issued
Debt Conversion, Converted Instrument, Amount
Non-cash exchange of Series Seed Convertible Preferred Stock for Company Series A non-voting convertible preferred stock
Subsequent Events
Subsequent Events
Parade [Member]
Parade.
Parade
Asset Class [Axis]
Investments, Debt and Equity Securities [Abstract]
Weighted Average Grant date fair value, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
2018 Plan [Member]
2018 Plan
Business Combination, Recognized Liability Assumed, Other Liability, Current
Other current liabilities
Current assets:
Current assets:
Liabilities, Fair Value Disclosure
Total liabilities
Accrued professional and consulting
Accrued Professional Fees, Current
Sale of Stock, Consideration Received on Transaction
Aggregate principal amount
Shares sold, aggregrate offering price
Related Party Transaction [Domain]
Sublicense Agreement and Any Amendments Period
Sublicense agreement and any amendments period.
Sublicense agreement and any amendments period
Leases [Abstract]
Temporary Equity, Shares, Conversion of Convertible Securities
Temporary equity, shares, conversion of convertible securities.
Temporary equity, exchange of series seed convertible preferred stock for series a non-voting convertible preferred stock upon the closing of the reverse recapitalization (in shares)
Document Fiscal Year Focus
Stock And Warrants Issued During Period, Shares, Reverse Recapitalization
Stock and warrants issued during period, shares, reverse recapitalization.
Issuance of common stock and pre-funded warrants in the Pre-Closing Financing, shares
Issuance of common stock and pre-funded warrants in the Pre-Closing Financing (in shares)
Accretion (Amortization) of Discounts and Premiums, Investments
Accretion/amortization on investments
Accretion/amortization on investments
Classification of Convertible Preferred Stock
Preferred Stock, Redeemable [Policy Text Block]
Common stock, shares outstanding
Common stock, shares outstanding
Common Stock, Shares, Outstanding, Ending Balance
Common Stock, Shares, Outstanding, Beginning Balance
JADE-002
Jade zero zero two.
JADE Zero Zero Two [Member]
Stock And Warrants Issued During Period, Value, Reverse Recapitalization
Stock and warrants issued during period, value, reverse recapitalization.
Issuance of common stock and pre-funded warrants in the Pre-Closing Financing
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Financial Instruments [Domain]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Aggregate Intrinsic Value, Vested and exercisable
Aggregate intrinsic value, vested and exercisable
Series Seed Convertible Preferred Stock [Member]
Series seed convertible preferred stock.
Series Seed Convertible Preferred Stock
Series Seed Preferred Stock
Stock converted (in shares)
Stock Converted, Reverse Recapitalization
Stock converted, reverse recapitalization.
Net Income (Loss) Attributable to Parent, Diluted
Net Income (Loss) Attributable to Parent, Diluted, Total
Net Loss attributable to common stockholders
Net loss, Diluted
Option Expiration Period
Option expiration period.
Option expiration period
Related Party [Member]
Related Party
Forecast [Member]
Forecast
Elected Not To Use the Extended Transition Period
Operating Lease, Liability, Noncurrent
Long-term lease liability
Adjustments to Additional Paid in Capital, Value, Issuance of Common Stock to Former Stockholders Upon Closing of Reverse Recapitalization
Adjustments to additional paid in capital, value, issuance of common stock to former stockholders upon closing of reverse recapitalization.
Issuance of common stock to former stockholders of Aerovate in connection with the closing of the reverse recapitalization
Total maturities
Lessee, Operating Lease, Liability, to be Paid
Total lease payment expected amount
Number of Operatring Lease
Number of operatring lease.
Number of operatring lease
Security Exchange Name
Measurement Input Type [Axis]
Related and Nonrelated Parties [Axis]
Recently Issued and Recently Adopted Accounting Pronouncements
Recently Issued Accounting Pronouncements Not yet Adopted
Stock Conversion Price Percentage
Stock conversion price percentage.
Conversion price percentage
Outstanding and issued warrant to Parade
Warrant
Class of Warrant or Right, Exercise Price of Warrants or Rights
Warrant exercise price per share
Entity Address, State or Province
Deferred Offering Costs in Accounts Payable or Accrued Expenses and Other Current Liabilities
Deferred offering costs in accounts payable or accrued expenses and other current liabilities.
Deferred offering costs in accounts payable or accrued expenses and other current liabilities
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Unrecognized stock-based compensation weighted-average period
Series A Preferred Stock [Member]
Series A Preferred Stock
Series A Non-voting Preferred Stock
Number of shares authorized
Number of shares authorized
Operating lease right-of-use assets
Operating lease right-of-use asset
Amendment Flag
Loss Contingencies [Table]
Right-of-use asset obtained in exchange for operating lease liability
Operating lease liability arising from obtaining right-of-use asset
Share-Based Payment Arrangement [Text Block]
Stock-Based Compensation
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Debt Instrument [Axis]
Other Nonoperating Income (Expense)
Other Nonoperating Income (Expense), Total
Other expense
Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total
Goodwill
Reverse Recapitalization [Abstract]
Reverse recapitalization.
City Area Code
Stock Issued During Period, Value, Employee Stock Purchase Plan
Issuance of stock under employee stock purchase plan
Preferred Stock [Member]
Preferred Stock
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Comprehensive Loss
Comprehensive Income, Policy [Policy Text Block]
Proceeds from Issuance of Common Stock
Proceeds from ATM Offering
Proceeds from at-the-market offerings, net of commissions
Operating expenses:
Operating expenses:
Deferred Offering Costs Reclassified From Other Assets To Equity
Deferred offering costs reclassified from other assets to equity.
Deferred offering costs reclassified from Other assets to equity
Related Party Accrued Expenses And Other Current Liabilities
Related party accrued expenses and other current liabilities
Related party accrued expenses and other current liabilities.
Common stock, par value
Common stock, par value
Common Stock Value Per Share
Legal Entity [Axis]
Leases
Lessee, Leases [Policy Text Block]
Pre-Merger Jade Common Stock [Member]
Pre-Merger Jade common stock.
Pre-Merger Jade Common Stock
Liabilities, Current
Total current liabilities
Leasehold Improvements [Member]
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Segment Reporting
Segment Reporting [Text Block]
JADE-003 [Member]
JADE-003
JADE301
Debt Securities, Available-for-Sale [Table Text Block]
Summary of Investment Portfolio
Defined Contribution Plan, Cost
Expense related to 401(k) Plan match contributions
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Trading Symbol
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
Weighted-average number of shares of as-converted (in shares)
Fair Value Measurement, Policy [Policy Text Block]
Fair Value Measurements
Proceeds from Issuance of Convertible Preferred Stock
Gross proceeds from issuance of convertible preferred stock
Subsequent Event [Table]
Weighted- Average Remaining Contractual Term, Vested and exercisable
Weighted- average remaining contractual term, vested and exercisable (in years)
Restricted stock units award
Number of RSUs and RSAs, Granted
Entity Emerging Growth Company
Foreign currency translation adjustment
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax
Currency translation adjustment
Additional Paid-in Capital [Member]
Additional Paid-In Capital
Plan Name [Domain]
APRIL [Member]
APRIL.
APRIL
Accrued liabilities and other liabilities current.
Accrued and other current liabilities
Total accrued and other current liabilities
Accrued expenses and other current liabilities
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Issuance of stock under ESPP, shares
Issuance of stock under employee stock purchase plan, (in shares)
US Treasury Securities [Member]
U.S. Treasury Securities
Aggregate intrinsic value of options exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value
Supplemental disclosure of noncash investing and financing activities:
Supplemental disclosure of non-cash operating, investing, and financing activities:
Cover [Abstract]
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Schedule of Assumptions Related to The Change in Fair Value
Payments to Acquire Investments
Payments to Acquire Investments, Total
Purchases of investments
Series A Non Voting Convertible Preferred Stock [Member]
Series A non voting convertible preferred stock.
Series A Non-voting Convertible Preferred Stock
Convertible Notes Payable, Noncurrent
Convertible Notes payable
Convertible Notes payable, noncurrent
Long-Term Debt, Type [Domain]
Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent
Percentage of diluted stock
Nonvested Restricted Stock Shares Activity [Table Text Block]
Schedule Of Restricted Stock Units and Restricted Stock Awards Activity
Professional Fees
Professional fees and services
General and administrative professional, consulting, and other fees
JADE Two Zero One [Member]
JADE two zero one.
JADE201
Terminated Period
Terminated period.
Terminated period
Accumulated other comprehensive (loss) income
Accumulated other comprehensive (loss) income
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Concentrations of Credit Risk
Stock Issued During Period, Value, Acquisitions
Issuance of common stock to former stockholders of Aerovate in connection with the closing of the reverse recapitalization
Stock-based compensation expense
Stock-based compensation
Stock-based compensation expense
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Summary of Changes in The Fair Value of Level 3
Additional paid-in capital
Additional paid-in capital
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Short-Term Investments
Short-Term Investments, Total
Investments
Warrants exercised
Warrants Exercised
Warrants exercised.
Fair Value Disclosures [Abstract]
Cash and cash equivalents
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value, Total
Payments of Debt Issuance Costs
Issuance costs offering
Issuance costs offering
Two Thousand Twenty Five Employee Stock Purchase Plan [Member]
Two thousand twenty five employee stock purchase plan.
2025 Employee Stock Purchase Plan
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Net cash provided by financing activities
Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]
Other comprehensive income (loss):
Other comprehensive loss:
Payables and Accruals [Abstract]
Net Income (Loss) Available to Common Stockholders, Basic
Net Income (Loss) Available to Common Stockholders, Basic, Total
Loss Allocation, Basic
Cash Equivalents, at Carrying Value
Cash equivalents
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Number of options, forfeited
Number of options, forfeited
Entity Filer Category
Debt Instrument, Name [Domain]
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Segment reporting, CODM, profit (loss) measure, how used, description
Stock Issued During Period, Shares, Exercise of Pre Funded Warrants
Stock issued during period, shares, exercise of pre-funded warrants.
Issuance of common stock in connection with exercise of pre-funded warrants (in shares)
Marketable Securities, Current
Current marketable securities
Time from Convertible Notes issuance to Next Equity Financing (in years)
Measurement Input Time from Convertible Notes issuance to Next Equity Financing [Member]
Measurement input time from convertible notes issuance to next equity financing.
Preferred Stock, Convertible, Conversion Ratio
Preferred stock convertible ratio
Property and equipment, net
Property and equipment, net
Reimburse for Development Costs
Reimburse for development costs.
Reimburse for developlment costs
Shares, Outstanding
Ending balance (in shares)
Beginning balance (in shares)
Segment Reporting
Entity Address, Postal Zip Code
Condensed Consolidated Balance Sheets
JADE101
JADE One Zero One [Member]
JADE one zero one.
Local Phone Number